Cas no 130812-04-3 (N'-{(1E)-2-[(14E)-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]ethylidene}acetohydrazide)

N'-{(1E)-2-[(14E)-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]ethylidene}acetohydrazide structure
130812-04-3 structure
Product Name:N'-{(1E)-2-[(14E)-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]ethylidene}acetohydrazide
CAS No:130812-04-3
MF:C33H55N3O9
MW:637.804510354996
CID:1226798
PubChem ID:9577442
Update Time:2025-04-20

N'-{(1E)-2-[(14E)-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]ethylidene}acetohydrazide Chemical and Physical Properties

Names and Identifiers

    • N'-{(1E)-2-[(14E)-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]ethylidene}acetohydrazide
    • LogP
    • N-[(E)-2-[(14E)-9-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]ethylideneamino]acetamide
    • 6108A1
    • Antibiotic 6108A1
    • 6108 A(sub 1)
    • Cirramycin A(sub 1), 20-(acetylhydrazone)
    • Cirramycin A1, 20-(acetylhydrazone)
    • Antibiotic 6108 A(sub 1)
    • 130812-04-3
    • Inchi: 1S/C33H55N3O9/c1-10-27-21(5)31-33(7,45-31)13-11-25(38)18(2)15-23(12-14-34-35-22(6)37)30(20(4)26(39)17-28(40)43-27)44-32-29(41)24(36(8)9)16-19(3)42-32/h11,13-14,18-21,23-24,26-27,29-32,39,41H,10,12,15-17H2,1-9H3,(H,35,37)/b13-11+,34-14-/t18-,19+,20+,21-,23+,24+,26-,27-,29+,30-,31+,32+,33+/m1/s1
    • InChI Key: BEYPIGLXIHAEAA-DRNJPBGBSA-N
    • SMILES: O1[C@@]2([C@@H]1[C@H](C)[C@@H](CC)OC(C[C@@H](O)[C@H](C)[C@@H](O[C@H]1[C@@H](O)[C@@H](N(C)C)C[C@H](C)O1)[C@@H](C/C=N\NC(C)=O)C[C@@H](C)C(C=C2)=O)=O)C |t:42,&1:1,2,3,5,11,13,15,17,18,20,25,28,37|

Computed Properties

  • Exact Mass: 637.39383
  • Monoisotopic Mass: 637.39383
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 3
  • Hydrogen Bond Acceptor Count: 11
  • Heavy Atom Count: 45
  • Rotatable Bond Count: 7
  • Complexity: 1080
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 13
  • Defined Bond Stereocenter Count: 2
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 160
  • XLogP3: 2.299

Experimental Properties

  • Density: 1.257
  • Boiling Point: °Cat760mmHg
  • Flash Point: °C
  • Refractive Index: 1.567

N'-{(1E)-2-[(14E)-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-9-{[3,4,6-trideoxy-3-(dimethylamino)hexopyranosyl]oxy}-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]ethylidene}acetohydrazide Related Literature

Recommended suppliers
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhangzhou Sinobioway Peptide Co.,Ltd.
Zhejiang Brunova Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.